These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 30695453)
1. [EFFECTIVENESS OF APPLICATION OF COMBINED THERAPY OF EARLY ERYTHEMA STAGE OF LYME DISEASE TAKING INTO CONSIDERATION IMMUNOGENESIS FEATURES]. Sorokina EV; Akhmatova NK; Skhodova SA; Chalaya EL; Masyukova SA Zh Mikrobiol Epidemiol Immunobiol; 2016 May; (3):51-56. PubMed ID: 30695453 [TBL] [Abstract][Full Text] [Related]
2. [Influence of immunovac-VP-4 therapy on innate immunity effectors in patients with darier erythema annulare centrifugum]. Sorokina EV; Akhmatova NK; Skhodova SA Zh Mikrobiol Epidemiol Immunobiol; 2013; (6):87-94. PubMed ID: 24605681 [TBL] [Abstract][Full Text] [Related]
3. [Features of dynamics of sera cytokines in patients with erythema multiforme during immunotherapy]. Sorokina EV; Akhmatova NK; Khomenkov VG Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):36-41. PubMed ID: 24738292 [TBL] [Abstract][Full Text] [Related]
4. [Effect of proteflazid on TLRs expression by mononuclear leukocytes of peripheral blood and epithelial cells of mucous membranes and skin in patients with herpes-associated erythema multiforme and erythema annulare centrifugum]. Sorokina EV; Akhmatova NK; Skhodova SA Eksp Klin Farmakol; 2014; 77(3):28-32. PubMed ID: 24800523 [TBL] [Abstract][Full Text] [Related]
5. Coevolution of markers of innate and adaptive immunity in skin and peripheral blood of patients with erythema migrans. Salazar JC; Pope CD; Sellati TJ; Feder HM; Kiely TG; Dardick KR; Buckman RL; Moore MW; Caimano MJ; Pope JG; Krause PJ; Radolf JD; J Immunol; 2003 Sep; 171(5):2660-70. PubMed ID: 12928420 [TBL] [Abstract][Full Text] [Related]
6. Comparison of phenoxymethylpenicillin, amoxicillin, and doxycycline for erythema migrans in general practice. A randomized controlled trial with a 1-year follow-up. Eliassen KE; Reiso H; Berild D; Lindbæk M Clin Microbiol Infect; 2018 Dec; 24(12):1290-1296. PubMed ID: 29505880 [TBL] [Abstract][Full Text] [Related]
7. Analysis of some peripheral blood lymphocyte subsets in relation to Borrelia burgdorferi antibodies in patients with Lyme disease. Zajkowska JM; Hermanowska-Szpakowicz T; Wysocka J; Kondrusik M; Pancewicz SA; Grygorczuk S Rocz Akad Med Bialymst; 2000; 45():184-98. PubMed ID: 11712430 [TBL] [Abstract][Full Text] [Related]
8. [Effect of Immunovac-VP-4 and Kagocel immunotherapy on cytokine levels in patients with erythema nodosum]. Sorokina EV; Akhmatova NK; Khomenkov VG; Akhmatov ÉA Eksp Klin Farmakol; 2013; 76(7):27-30. PubMed ID: 24006613 [TBL] [Abstract][Full Text] [Related]
9. [Lyme borreliosis--the most frequent vector-borne infection in Denmark]. Lebech AM; Hansen K Ugeskr Laeger; 2004 Jun; 166(25):2431-3. PubMed ID: 15283107 [No Abstract] [Full Text] [Related]
10. [Therapeutic bacterial vaccine Immunovac in complex treatment of patients with chronic pyoderma]. Sorokina EV; Masiukova SA; Kurbatova EA; Egorova NB Zh Mikrobiol Epidemiol Immunobiol; 2010; (4):31-7. PubMed ID: 20795383 [TBL] [Abstract][Full Text] [Related]
11. The Lyme disease vaccine takes its toll. Thomas V; Fikrig E Vector Borne Zoonotic Dis; 2002; 2(4):217-22. PubMed ID: 12804162 [TBL] [Abstract][Full Text] [Related]
12. Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Wormser GP; Ramanathan R; Nowakowski J; McKenna D; Holmgren D; Visintainer P; Dornbush R; Singh B; Nadelman RB Ann Intern Med; 2003 May; 138(9):697-704. PubMed ID: 12729423 [TBL] [Abstract][Full Text] [Related]
13. Subclinical Lyme borreliosis is common in south-eastern Sweden and may be distinguished from Lyme neuroborreliosis by sex, age and specific immune marker patterns. Carlsson H; Ekerfelt C; Henningsson AJ; Brudin L; Tjernberg I Ticks Tick Borne Dis; 2018 Mar; 9(3):742-748. PubMed ID: 29502989 [TBL] [Abstract][Full Text] [Related]
14. Doxycycline versus tetracycline therapy for Lyme disease associated with erythema migrans. Nowakowski J; Nadelman RB; Forseter G; McKenna D; Wormser GP J Am Acad Dermatol; 1995 Feb; 32(2 Pt 1):223-7. PubMed ID: 7829706 [TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against lyme disease in healthy children and adolescents: a randomized controlled trial. Sikand VK; Halsey N; Krause PJ; Sood SK; Geller R; Van Hoecke C; Buscarino C; Parenti D; Pediatrics; 2001 Jul; 108(1):123-8. PubMed ID: 11433064 [TBL] [Abstract][Full Text] [Related]
16. Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis. Feder HM; Abeles M; Bernstein M; Whitaker-Worth D; Grant-Kels JM Clin Dermatol; 2006; 24(6):509-20. PubMed ID: 17113969 [TBL] [Abstract][Full Text] [Related]
17. Failure of Borrelia burgdorferi to survive in the skin of patients with antibiotic-treated Lyme disease. Berger BW; Johnson RC; Kodner C; Coleman L J Am Acad Dermatol; 1992 Jul; 27(1):34-7. PubMed ID: 1619074 [TBL] [Abstract][Full Text] [Related]
18. Advances in the treatment and prevention of Lyme borreliosis. Wormser GP; Stanek G; Strle F; Gray JS Wien Klin Wochenschr; 2005 Jun; 117(11-12):381-4. PubMed ID: 16053191 [No Abstract] [Full Text] [Related]
19. [Effect of antibiotic therapy on phagocytosis and oxidative metabolism of polymorphonuclear leukocytes in patients with Lyme arthritis]. Kondrusik M; Wysocka J; Lipartowska R; Zajkowska J; Pancewicz S; Hermanowska-Szpakowicz T Pol Merkur Lekarski; 2002 Sep; 13(75):204-7. PubMed ID: 12474571 [TBL] [Abstract][Full Text] [Related]
20. Effects of UV irradiation with one minimal erythema dose on human afferent skin lymph in vivo. Yawalkar N; Aebischer MC; Hunger R; Brand CU; Braathen LR Exp Dermatol; 1998 Dec; 7(6):362-8. PubMed ID: 9858139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]